ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

DCT board Okays Recompetition of Clinical Trials Contracts

October 29, 1993

NCCS Networker Volume 5 Issue 2, Spring 1991

April 13, 1991

In Brief: Clark Wins Sheen award; Research Training Cuts Prompt PhD Holders To Apply Medical Schools

July 12, 1974

NCI Begins Latin American Cancer Research Network

April 10, 2009

House Authorizes $30M For Pediatric Cancer Research.

June 13, 2008

Majority Of Americans Would Consider Participating In Clinical Trials, Study Finds

March 28, 2003